Related Experiment Videos
Is prevention of cancer possible with tumor-specific vaccines?
1Hacettepe University Medical School, Department of Hematology, Ankara, Turkey.
Abstract:
Cancer is one of the leading causes of death today, and new therapeutic approaches are continuously being explored. In recent years, cancer vaccines have been tried with the aim of induction of an active specific immune response against the tumor. Although some successful results are obtained, cure rates are still disappointing. The main reason for failure is that vaccines are applied to patients diagnosed with cancer; in these patients, tumor cell burden is so high that it is almost impossible to overcome the disease by increasing the immune response with vaccines at this stage. This hypothesis is based on the following idea: since therapy for cancer is unsuccessful in the majority of patients, methods of prevention should be improved. Immunization against microorganisms has largely prevented morbidity and mortality from infectious disease. In a similar way, if we immunize people before the development of malignant disease with tumor-specific vaccines, then prevention of cancer may be possible.
Insights
Cancer vaccines show limited success in treatment due to high tumor burden. Preventive cancer vaccines, similar to those for infectious diseases, may offer a more effective strategy for cancer prevention.
Area of Science:
- Oncology
- Immunology
- Preventive Medicine
Background:
- Cancer remains a leading cause of death globally, driving the search for novel therapeutic strategies.
- Cancer vaccines aim to stimulate an active immune response against tumors, but current treatment outcomes are often disappointing.
- A key limitation of current cancer vaccines is their administration to patients with established, high tumor burdens, hindering efficacy.
Purpose of the Study:
- To explore the potential of preventive cancer vaccines as a strategy for cancer control.
- To hypothesize that early immunization before malignancy development could prevent cancer, drawing parallels with infectious disease prevention.
Main Methods:
- The study is primarily a hypothesis-driven conceptual exploration.
- It reviews the principles of active specific immunotherapy and compares them to successful vaccination strategies for infectious diseases.
Main Results:
- Current cancer vaccine therapy in patients with diagnosed cancer yields limited success due to high tumor cell burden.
- The hypothesis proposes that prophylactic immunization with tumor-specific vaccines could prevent cancer development.
Conclusions:
- Preventive strategies, particularly immunization before cancer onset, may be more effective than therapeutic approaches for cancer control.
- Further research into tumor-specific vaccines for cancer prevention is warranted based on this hypothesis.